The Invention for Innovation (i4i) programme is a translational research funding scheme aimed at de-risking early-to-late stage medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use.
Open date: 23/03/2022
Close date: 27/04/2022
Funding Type: Grant
Fund Provider(s): i4i
Industries: Health and Lifescience, medicine
i4i Challenge Awards support market-ready innovations by addressing the translational gap between the clinical evaluation of technologies and their adoption, by funding the assessment of MedTech innovations in real-world healthcare settings. The expected output is a disruptive medical device or in vitro diagnostic test that can offer improved outcomes for NHS patients. There is no upper funding limit for the Challenge Awards, but costs must be fully justified.
Key eligibility criteria
Projects can be led by SMEs, NHS providers or higher education institutions (HEIs).
A minimum of two organisations must be involved and at least one of the collaborators must be from an NHS provider (e.g. an NHS Trust).
Technologies must have demonstrated safety and efficacy and must have obtained or be in the process of obtaining CE marking.
Project timelines can vary based on the required evidence for potential healthcare uptake and patient benefit. They can last up to 3 years, but a duration of up to 5 years will be considered if a longer period is needed to demonstrate long-term outcomes and a strong case is made.
Lead applicants must be based in England.
Inovasi helps companies to innovate with innovation incentives: R&D, Tax Credits, The Patent Box Scheme, and Funding. Inovasi aims to save you time, so you can focus on the core of your business, we offer expert advice, you can rest easy knowing your claim has been strictly adhered to HMRC legislation, reducing the chance of an inquiry, maximise all aspects of your innovation process, experienced, up to date on the latest guidance and changes related to grants.